Tecfidera News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tecfidera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tecfidera Today - Breaking & Trending Today

Biogen Gets Favorable EU Court Ruling For TECFIDERA Regulatory Data And Marketing Protection

WESTON (dpa-AFX) - Biotechnology company Biogen Inc. (BIIB) announced Thursday a favorable decision from the Court of Justice of the European Union relating to TECFIDERA (dimethyl fumarate) regulatory ....

Dennis Riedl , European Union , European Medicines Agency , European Commission , Biogen Inc , General Court ,

Biogen Inc.: Biogen Receives Favorable Decision from Court of Justice of the European Union Relating to TECFIDERA® (dimethyl fumarate) Regulatory Data and Marketing Protection

CAMBRIDGE, Mass., March 16, 2023(Nasdaq: BIIB) today announced that the Court of Justice of the European Union decided in favor of Biogen, the European Medicines Agency (EMA), and the European Commission ....

United Kingdom , Dennis Riedl , Mike Hencke , Jack Cox , European Commission , Exchange Commission , European Union , European Medicines Agency , General Court , Full Year ,

European Patent Office Grants Patent Related to TECFIDERA® (Dimethyl Fumarate)

Patent covers approved dosing regimen for TECFIDERA and expires in 2028 CAMBRIDGE, Mass., June 21, 2022 Biogen Inc. today announced that the European Patent Office has granted a patent that. | June 21, 2022 ....

United Kingdom , Ashleigh Koss , Mike Hencke , Walter Gilbert , Charles Weissmann , Heinz Schaller , Kenneth Murray , European Patent Office , Biogen Inc , European Patent Convention , Exchange Commission , European Medicines Agency , European Patent Office Examining Division , European Patent , European Patent Bulletin , Important Safety Information , Prescribing Information , Patient Information , Sir Kenneth Murray , Nobel Prize , Healthy Lives , Safe Harbor , Private Securities Litigation Reform Act , Biogen Inc Stock Exchange , Press Release , Atent Biib Us09062x1037 ,

Viatris Says Defeats Biogen's Attempt To Revive Tecfidera Patent

CANONSBURG (dpa-AFX) - Viatris Inc. (VTRS) said that the United States Court of Appeals for the Federal Circuit denied Biogen's request that the Court reconsider its prior decision affirming the ....

United States , United States Court , Viatris Inc , Mylan Pharmaceuticals Inc , Federal Circuit , Mylan Pharmaceuticals ,

Biogen's Tecfidera patent contingency plan falls flat amid sputtering Aduhelm launch

Biogen’s contingency plan to keep Tecfidera generics at bay has fallen flat. ....

Multiple Sclerosis , Patent Litigation , Patent Lawsuit , Patent Laws , Fierce Pharma Homepage ,